Agreement will facilitate worldwide commercialization of groundbreaking biomarkers for ASD, Parkinson's disease and concussion
https://www.prnewswire.com/news-releases/quadrant-biosciences-enters-into-licensing-agreements-with-suny-upstate-and-penn-state-for-commercialization-of-novel-epigenetic-biomarkers-300627618.html